218 related articles for article (PubMed ID: 24205724)
21. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
[TBL] [Abstract][Full Text] [Related]
22. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
Heeren J; Niemeier A; Merkel M; Beisiegel U
J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
[TBL] [Abstract][Full Text] [Related]
23. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
[TBL] [Abstract][Full Text] [Related]
24. [Alcohol and plasma lipoproteins in acute and long-term studies].
Mordasini R; Kaffarnik H; Schneider J; Riesen W
Schweiz Med Wochenschr; 1982 Dec; 112(52):1928-31. PubMed ID: 7163806
[TBL] [Abstract][Full Text] [Related]
25. [Hypertriglyceridemia-induced pancreatitis].
Nagayama D; Shirai K
Nihon Rinsho; 2013 Sep; 71(9):1602-5. PubMed ID: 24205721
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
Granot E
Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
[TBL] [Abstract][Full Text] [Related]
27. Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins.
Hennig B; Chung BH; Watkins BA; Alvarado A
Atherosclerosis; 1992 Aug; 95(2-3):235-47. PubMed ID: 1418097
[TBL] [Abstract][Full Text] [Related]
28. [Abnormal lipoprotein metabolism in CKD].
Hirano T
Nihon Jinzo Gakkai Shi; 2013; 55(7):1276-9. PubMed ID: 24288963
[No Abstract] [Full Text] [Related]
29. Dialysis removes apolipoprotein C-I, improving very low-density lipoprotein clearance.
Kaysen GA
Kidney Int; 2007 Oct; 72(7):779-81. PubMed ID: 17882238
[TBL] [Abstract][Full Text] [Related]
30. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
Liang K; Oveisi F; Vaziri ND
Kidney Int; 1998 Mar; 53(3):626-30. PubMed ID: 9507207
[TBL] [Abstract][Full Text] [Related]
31. [Current progress in lipoprotein lipase and atherosclerosis].
Tian GP; Chen WJ; He PP; Yin WD; Tnag CK
Sheng Li Ke Xue Jin Zhan; 2012 Oct; 43(5):345-50. PubMed ID: 23316606
[TBL] [Abstract][Full Text] [Related]
32. The triglyceride connection in atherosclerosis.
Geurian K; Pinson JB; Weart CW
Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678
[TBL] [Abstract][Full Text] [Related]
33. [TG-rich lipoprotein metabolism and regulatory factors].
Masuda D
Nihon Rinsho; 2013 Sep; 71(9):1514-6. PubMed ID: 24205708
[No Abstract] [Full Text] [Related]
34. Low-Density Lipoprotein Receptor Signaling Mediates the Triglyceride-Lowering Action of Akkermansia muciniphila in Genetic-Induced Hyperlipidemia.
Shen J; Tong X; Sud N; Khound R; Song Y; Maldonado-Gomez MX; Walter J; Su Q
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1448-56. PubMed ID: 27230129
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein metabolism in chronic renal insufficiency.
Saland JM; Ginsberg HN
Pediatr Nephrol; 2007 Aug; 22(8):1095-112. PubMed ID: 17390152
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein metabolism and CKD: overview.
Barter P
Clin Exp Nephrol; 2014 Apr; 18(2):243-6. PubMed ID: 24052157
[TBL] [Abstract][Full Text] [Related]
37. A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
Fujita K; Maeda N; Kozawa J; Murano K; Okita K; Iwahashi H; Kihara S; Ishigami M; Omura M; Nakamura T; Shirai K; Yamamura T; Funahashi T; Shimomura I
Intern Med; 2010; 49(22):2467-72. PubMed ID: 21088351
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiology of hypertriglyceridemia.
Hassing HC; Surendran RP; Mooij HL; Stroes ES; Nieuwdorp M; Dallinga-Thie GM
Biochim Biophys Acta; 2012 May; 1821(5):826-32. PubMed ID: 22179026
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
Connelly PW; Maguire GF; Vezina C; Hegele RA; Kuksis A
J Biol Chem; 1994 Aug; 269(32):20554-60. PubMed ID: 8051155
[TBL] [Abstract][Full Text] [Related]
40. Limited effects of systemic or renal lipoprotein lipase deficiency on renal physiology and diseases.
Fujino Y; Yasuda-Yamahara M; Tanaka-Sasaki Y; Kuwagata S; Yamahara K; Tagawa A; Chin-Kanasaki M; Yanagita M; Maegawa H; Kume S
Biochem Biophys Res Commun; 2022 Sep; 620():15-20. PubMed ID: 35772212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
